Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Strategic pipeline prioritization with workforce and cost reductions expected to extend the company’s cash runway by one year into H2 2027 -- -- Two robust clinical datasets from CB-010 and CB-011 now ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable ...